Navigation Links
UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
Date:9/1/2011

ANAHEIM, Calif., Sept. 1, 2011 /PRNewswire/ -- Please replace the release dated August 24, 2011 with the following updated version.  First graph, second and third sentences added and should read: The Company will provide attendees an updated investor presentation, which will be filed in a Form 8K with the SEC after the close of the U.S. financial markets on Friday, September 9, 2011.  This presentation will also be available at http://ir.questcor.com/sec.cfm.  Second graph, second and third sentences updated and should read: Don M. Bailey, President and Chief Executive Officer, and members of the executive management team are scheduled to provide an overview of the Company in an "unplugged" fireside chat and Q&A session on Wednesday, September 14, 2011 at 8:00 a.m. ET.  A live audio only webcast and subsequent archived replay of the discussion will be accessible at http://ir.questcor.com/events.cfm.

The full updated release reads:

Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September

Questcor Pharmaceuticals, Inc. (NASDAQ:  QCOR) announced today that members of its executive management team will present at the following investor conferences in early September.  The Company will provide attendees an updated investor presentation, which will be filed in a Form 8K with the SEC after the close of the U.S. financial markets on Friday, September 9, 2011.  This presentation will also be available at http://ir.questcor.com/sec.cfm.

  • The Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York City.  Don M. Bailey, President and Chief Executive Officer, and members of the executive management team are scheduled to provide an overview of the Company in an "unplugged" fireside chat and Q&A session on Wednesday, September 14, 2011 at 8:00 a.m. ET.  A live audio only webcast and subsequent archived replay of the discussion will be accessible at http://ir.questcor.com/events.cfm.
  • UBS Global Life Sciences Conference at the Grand Hyatt in New York City.  Mr. Bailey is scheduled to present on Monday, September 19, 2011 at 10:30 a.m. ET.  A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm.

About Questcor

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company whose primary product helps patients with serious, difficult-to-treat medical conditions.  Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications.  Of these 19 indications, Questcor currently generates substantially all of its net sales from three indications: the treatment of acute exacerbations of multiple sclerosis in adults, the treatment of nephrotic syndrome, and the treatment of infantile spasms in children under two years of age. With respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus."  Questcor is also exploring the use of Acthar to treat systemic lupus erythematosus, for which Acthar is approved as both a maintenance therapy and to treat exacerbations.  Questcor is also exploring the possibility of developing markets for other on-label indications and the possibility of pursuing FDA approval of additional indications not currently on the Acthar label where there is high unmet medical need.  For more information, please visit www.questcor.com.


'/>"/>
SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011
2. Questcor to Report Second Quarter 2011 Earnings and Conduct Conference Call on July 26, 2011
3. Questcor Proxy Proposals All Approved at 2011 Shareholder Meeting
4. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
5. Questcor to Report First Quarter 2011 Earnings and Conduct Conference Call on April 26, 2011
6. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011
7. Questcor Pharmaceuticals to Present at the Needham Healthcare Conference
8. Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
9. Questcor Pharmaceuticals Selects BDO USA as its Auditor
10. Questcor Reports 2010 Financial Results
11. Questcor to Report Fourth Quarter and Full Year 2010 Earnings and Conduct Conference Call on February 23, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 12, 2017 West Pharmaceutical Services, Inc. ... for injectable drug administration, today announced that it will ... on Thursday, October 26, 2017, and will follow with ... expectations at 9:00 a.m. Eastern Time. To participate on ... The conference ID is 94093362. ...
(Date:10/10/2017)... 2017  NDS received FDA 510(k) clearance in May 2017 for ... stand specifically designed for endoscopy environments. An innovative secondary monitor solution, ... solution to support the improvement of patient outcomes, procedural efficiency, and ... ... ...
(Date:10/4/2017)... Centers for Disease Control and Prevention (CDC), influenza vaccination should take ... communities across Massachusetts , Connecticut , ... through the end of the month. *Some exclusions apply ... ... by the end of October, according to the Centers for Disease Control ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
Breaking Medicine News(10 mins):